Unionview LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.61M Hold
2,085
1.18% 19
2024
Q3
$1.85M Hold
2,085
1.44% 16
2024
Q2
$1.89M Hold
2,085
1.54% 16
2024
Q1
$1.62M Buy
2,085
+6
+0.3% +$4.27K 1.34% 18
2023
Q4
$1.21M Hold
2,079
1.09% 21
2023
Q3
$1.12M Sell
2,079
-52
-2% -$26.8K 1.06% 23
2023
Q2
$1,000K Hold
2,131
0.91% 22
2023
Q1
$732K Buy
2,131
+61
+3% +$20.6K 0.69% 24
2022
Q4
$757K Hold
2,070
0.76% 24
2022
Q3
$669K Sell
2,070
-90
-4% -$28.5K 0.76% 23
2022
Q2
$700K Hold
2,160
0.78% 23
2022
Q1
$619K Buy
2,160
+9
+0.4% +$2.32K 0.58% 33
2021
Q4
$594K Buy
+2,151
New +$545K 0.56% 37

Other funds holding LLY

Unionview LLC's LLY Position: Q4 2024 in Review

Unionview LLC held its Eli Lilly (LLY) position steady in Q4 2024 at 2,085 shares worth $1.61M. The position accounts for 1.18% of the portfolio, ranked #19.

Unionview LLC first reported a position in LLY in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.89M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Unionview LLC held 2,085 shares of Eli Lilly worth $1.61M as of Q4 2024.
  • Unionview LLC left its Eli Lilly share count unchanged in Q4 2024.
  • Eli Lilly made up 1.18% of Unionview LLC's portfolio in Q4 2024, its #19 holding.
  • Unionview LLC first reported a position in Eli Lilly in Q4 2021 and has held it in 13 quarters since.
  • Unionview LLC's Eli Lilly position peaked at $1.89M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.